AI assistant
Sending…
ROCKET PHARMACEUTICALS, INC. — Director's Dealing 2019
Nov 6, 2019
33148_dirs_2019-11-06_e11c2d96-3332-40b7-8291-9ebd05b143b3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ROCKET PHARMACEUTICALS, INC. (RCKT)
CIK: 0001281895
Period of Report: 2019-10-28
Reporting Person: Alam Kamran (SVP - Finance & PFO)
More from ROCKET PHARMACEUTICALS, INC.
Regulatory Filings
2026
May 21
Regulatory Filings
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 6
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 27
Regulatory Filings
2026
Mar 2
Regulatory Filings
2026
Feb 26
Annual Report
2026
Feb 26
Director's Dealing
2026
Feb 20
Director's Dealing
2026
Feb 20